Evidence map›Paper›PMID 35417701›Full record

ArticleCell reports2022

Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults.

Winston E Anthony, Bin Wang, Kimberley V Sukhum, Alaric W D'Souza, Tiffany Hink, Candice Cass, Sondra Seiler, Kimberly A Reske, Christopher Coon, Erik R Dubberke and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06791993 (Impact of Probiotics Combined with Antibiotic Prophylaxis on Gut Microbiome Balance in Patients Undergoing Elective Orthopedic Surgery, Double-Blinded Randomized Controlled Trial), which is not on this map. Cited by 141 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 1 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06791993 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Impact of Probiotics Combined with Antibiotic Prophylaxis on Gut Microbiome Balance in Patients Undergoing Elective Orthopedic Surgery, Double-Blinded Randomized Controlled Trial

TypeinterventionalSponsorAcibadem Maslak HospitalRan2025 to 2025Enrolled60ConditionsDysbiosis, Gut -microbiota, Microbiome Analysis, ProbioticArmsPlacebo Capsule, Probiotic with Human Milk Oligosaccharides (HMO)
3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 1 synthesis or guideline pooled it, 197 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Winston E AnthonyThe Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Bin WangThe Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kimberley V SukhumThe Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Alaric W D'SouzaThe Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Tiffany HinkDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Candice CassDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Sondra SeilerDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kimberly A ReskeDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Christopher CoonDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Erik R DubberkeDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Carey-Ann D BurnhamDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: cburnham@wustl.edu.
Gautam DantasThe Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA. Electronic address: dantas@wustl.edu.
Jennie H KwonDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: j.kwon@wustl.edu.
Washington University in St. Louis · US

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Longitudinal Analysis of the Fecal Microbiome and Resistome of Patients with Multidrug-Resistant Urinary Tract Infections and Predictors of RecurrenceK23AI137321 · NIAID · WASHINGTON UNIVERSITY · PI KWON, JENNIE H · 2019 to 2022
$675k
NIAID NIH HHS K23 AI137321NIGMS NIH HHS T32 GM007067NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

Antibiotics are deployed against bacterial pathogens, but their targeting of conserved microbial processes means they also collaterally perturb the commensal microbiome. To understand acute and persistent effects of antibiotics on the gut microbiota of healthy adult volunteers, we quantify microbiome dynamics before, during, and 6 months after exposure to 4 commonly used antibiotic regimens. We observe an acute decrease in species richness and culturable bacteria after antibiotics, with most healthy adult microbiomes returning to pre-treatment species richness after 2 months, but with an altered taxonomy, resistome, and metabolic output, as well as an increased antibiotic resistance burden. Azithromycin delays the recovery of species richness, resulting in greater compositional distance. A subset of volunteers experience a persistent reduction in microbiome diversity after antibiotics and share compositional similarities with patients hospitalized in intensive care units. These results improve our quantitative understanding of the impact of antibiotics on commensal microbiome dynamics, resilience, and recovery.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAdultAnti-Bacterial AgentsBacteriaHumansSymbiosisAnti-Bacterial Agentsantibiotic resistanceCP: Microbiologyhost-microbe dynamicsmicrobial pathogenesismicrobiomepopulation dynamicstherapeutics

Identifiers

PMID35417701
PMCPMC9066705
OpenAlexW4223892782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.